Physician profile
Evan Krawitz
NPI 1790714665
$1,516.21
in general payments reported to CMS, 2019-2025
21 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $87.72 · 2021: $160 · 2022: $305 · 2023: $224 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $247.14 | 2019-2021 | |
| Alcon Vision LLC | $223.84 | 2019-2025 | Clareon |
| Rxsight INC | $129.38 | 2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Sun Pharmaceutical Industries INC. | $127.74 | 2019-2022 | |
| Glaukos Corporation | $126.88 | 2022 | |
| Sight Sciences, INC. | $121.04 | 2022-2023 | Omni Surgical System |
| Biotissue Holdings INC. | $76.99 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $76.10 | 2025 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $55.83 | 2019-2021 | |
| Oyster Point Pharma, INC. | $55.65 | 2022 | |
| Novartis Pharmaceuticals Corporation | $54.57 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $43.60 | 2020-2021 | |
| Alimera Sciences, INC. | $29.24 | 2020-2021 | |
| Shire North American Group INC | $29.24 | 2019 | |
| Travere Therapeutics, INC. | $22.08 | 2023 | Cholbam |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $20.00 | 2025 | Xdemvy |
| Ivantis, INC | $18.97 | 2020 | |
| Eyevance Pharmaceuticals LLC | $16.94 | 2021 | |
| Aerie Pharmaceuticals, INC. | $14.82 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.82 | 2020 | |
| Bausch & Lomb Americas INC. | $12.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Krawitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.